🇺🇸 FDA
Patent

US 11744876

Immunomodulator antibody drug conjugates and uses thereof

granted A61KA61K2039/572A61K38/1866

Quick answer

US patent 11744876 (Immunomodulator antibody drug conjugates and uses thereof) held by Sutro Biopharma, Inc. expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sutro Biopharma, Inc.
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K2039/572, A61K38/1866, A61K47/65, A61K47/6803